ANTIBIOTIC SUSCEPTIBILITY PATTERN OF ESCHERICHIA COLI ISOLATED FROM CHILDREN WITH URINARY TRACT INFECTION
Objective: This work aimed to detect the antibiotic susceptibility pattern of Escherichia coli isolated from children, as it is the most predominant pathogen of urinary tract infection (UTI).
Methods: About 530 urine samples were collected and tested using the modified Kirby–Bauer disk diffusion method to find the susceptibility pattern of isolated bacteria.
Results: Out of a total of 530 samples, 114 (21.50%) showed significant growth. A total of 8 different types of bacteria were isolated from the growth of positive samples. Among the isolates, E. coli 66 (57.8%) was found to be the most predominant organism followed by Klebsiella pneumoniae 18(15.8%), Proteus spp. 10 (8.8%), Staphylococcus aureus 8 (7.0%), Acinetobacter spp. 4 (3.5%), CoNS 4 (3.5%), Enterobacter spp. 2 (1.8%), and Pseudomonas aeruginosa 2 (1.8%). In the present study, out of 66 E. coli, 37 (56.1%) were multidrug-resistant strain. E. coli showed 94.0% resistance to ceftriaxone followed by ceftazidime 86.5% and cefotaxime 70.3%. Imipenem (91.9%) followed by amikacin (89.2%) seems to be the effective drug against UTI causing E. coli in children.
Conclusion: Multidrug resistance may possess difficulties with the choice of therapeutic options for the treatment of severe infections.
2. Benador D, Benador N, Slosman D. Are younger children at the highest risk of renal sequelae after pyelonephritis? Lancet 1997;349:17-9.
3. Chakrabotry P. A Textbook of Microbiology. 1st ed. Calcutta: New Central Book Agency Pvt. Ltd.; 2001.
4. Chang SL, Shortliffe LD. Pediatric urinary tract infections. Pediatr Clin North Am 2006;53:379-400.
5. Todar K. Pathogenic Escherichia coli Online Textbook of Bacteriology. United States: Department of Bacteriology, University of Wisconsin- Madison; 2008. p. 487-91.
6. Al-Badrl A, Al-Shaikh G. Recurrent urinary tract infections management in women: A review. Sultan Qaboos Univ Med J 2013;13:359-67.
7. Bhandari G, Pokhrel B, Oli Y, Kautwal A, Bhandari NL. Screening of methicillin-resistant Staphylococcus aureus (MRSA) from wounds in pediatric patients visiting tertiary care in the hospital. Nepal J Biotechnol 2019;7:82-9.
8. Lemonae L, Jahnukainen T, Mertsola J. Bacteremic urinary tract infection in children. Pediatr Infect Dis J 2004;19:630-4.
9. Patricia MT. Bailey and Scott’s, Diagnostic Microbiology. 13th ed. United States: Mosby; 2007. p. 123-6.
10. Cheesbrough M. Bacterial pathogens. In: District Laboratory Practices in Tropical Countries. Vol. 2. London: Cambridge University Press; 2006. p. 157-234.
11. CLSI. Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Third Informational Supplement. Wayne, PA: CLSI; 2013.
12. Santo E, Salvador MM, Marin JM. Multidrug-resistant urinary tract isolates of Escherichia coli from Ribeirao Preto, Sao Paulo, Brazil. Braz J Infect Dis 2007;11:575-8.
13. Al-Jebouri M, Mdish S. Antibiotic resistance pattern of bacteria isolated from patients of urinary tract infection in Iraq. Open J Urol 2013;3:131-6.
14. Fowler JE, Mariano M. Immunologic response of the prostate to bacteriuria and bacterial prostatitis. II. Antigen specific immunoglobulin in prostatic fluid. J Urol 1990;128:165-70.
15. Kahlmeter G. The ECO*SENS project: A prospective, multinational, multicentre epidemiological survey of the prevalence and antimicrobial susceptibility of urinary tract pathogens-interim report. J Antimicrob Chemother 2000;46:15-22.
16. Marquez C, Labbate M, Raymondo C, Fernandez J, Gestal AM, Holley M, et al. Urinary tract infectiona in a South American population: Dynamic spread of class 1 integrons and multidrug resistance by homologous and site-specific recombination. J Clin Microbiol 2008;46:3417-25.
17. Sarpong CK, Yenlii EM, Idriss A, Arhin AA, Aboah K, Azorliade R, et al. Bacterial urinary tract infection obstruction at Komfo Anokye teaching hospital, Kumasi, Ghana. Open J Urol 2012;2:131-6.
18. Steenberg J, Bartles ED, Bay-Nielsen H. Epidemiology of urinary tract diseases in general practice. Br Med J 1985;4:390-4.
19. Tessema B, Kassu A, Mulu A, Yismaw G. Pridominant isolates of urinary tract pathogens and their antimicrobial susceptiblity patterns in Gondar university teaching hospital, Nothwest Ethiopia. Ethiop Med J 2007;45:61-7.
20. Festo F, Hokororo A, Kidenya BR, Mshana SE. Predictors of urinary tract infection among febrile children attending at Bugando medical center Northwestern, Tanzania. Arch Clin Microbiol 2011;2:1-7.
21. Ismaili K, Lolin N, Damry M, Alexander P. Febrile urinary tract infections in 0-to 3-month-old infants: A prospective follow-up study. J Pediatr 2011;158:91-4.
22. Akram M, Shahid M, Khan AU. Etiology and antibiotic resistance patterns of community-acquired urinary tract infection in JNMC Hospital, Aligarh, India. Ann Clin Microbiol Antimicrob 2007;6:1-7.
23. Malla KK, Sharma MS, Malla T, Thapaliya A. Clinical profiles, bacterial isolates, and antibiotics susceptibility patterns in urinary tract infection in a children hospital-based study. J Nepal Paediatr Soc 2008;28:52-61.
24. Jesse D, Sammon PS, Haider R, Shysam S, James O. Predictors of admission in patients presenting to the emergency department with urinary tract infection. World J Urol 2013;10:1113-67.
25. Forbes BA, Sahm DF, Weissfield AS. Bailey, and Scott’s Diagnostic Microbiology. 12th ed. United States: Mosby; 2007.
26. Sharma A, Shrestha S, Upadhya S, Rijal P. Clinical and bacteriological profile of urinary tract infection in children at Nepal medical college teaching hospital. Nepal Med Coll J 2011;13:24-6.
27. Acharya A, Gautam R, Subedee L. Uropathogens and their antimicrobial susceptibility pattern in Bharatpur, Nepal. Nepal Med Coll J 2011;13:30-3.
28. Noor AF, Sharma F, Munshi SK, Hassan M, Noor R. Prevalence and antibiogram profile of uropathogens isolated from hospital and community patients with urinary tract infections in Dhaka city. J Bangladesh Acad Sci 2013;37:57-63.
29. Ramana BV, Chaudhury A. Prevalence of uropathogens in diabetic patients and their resistance pattern at a tertiary care Centre in South India. Int J Biol Med Res 2012;3:1433-5.
30. Livermore DM. Beta-lactamases in laboratory and clinical resistance. Clin Microbiol Rev 1995;8:557-84.
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.